Coleus hadiensis (Forssk.) A.J.Paton is a horticultural herb that goes to the Lamiaceae family. This plant species has been using to treat diarrhea, skin and digestive disorders, diabetes, and carcinoma in ethnomedicines. This minireview work purposes to analyze, summarize, and document the reported bioactivities of C. hadiensis. Suitable published works were obtained employing the Web of Science, Scopus, PubMed, Semantic Scholar, and ScienceDirect databases from 1900 to December 2020. Hitherto, in vitro level of scientific evidence is the highest level of scientific evidence available for the bioactivities of this plant species. Various parts of C. hadiensis exhibited antioxidant, antibacterial, anti-inflammatory, anticancer, and antimalarial activities in a range of assays. To date, eight bioactive (antimalarial and antioxidant) compounds have been isolated from C. hadiensis. This minireview analyzed, summarized, and documented the reported bioactivities of C. hadiensis. In addition, this minireview provides a basis for further bioactivities researches using C. hadiensis in future.
Vachellia leucophloea (Roxb.) Maslin, Seigler & Ebinger is a tree that fits into the Fabaceae family. V. leucophloea has been applied to heal including bronchitis, diabetes, high cholesterol, leprosy, and snakebite. Phytochemicals including betulinic acid-3-O-β-d-maltoside; Δ 7avenasterol; leucophleol; leucophleoxol; and leucoxol; have been isolated from bark, root, and leaf of this plant species. This systematic review article purposes to evaluate, outline, and document the bioactivities associated with available researches involving V. leucophloea. PubMed, Semantic Scholar, Scopus, ScienceDirect, and Web of Science electronic records were employed to find the applicable available works from 1900 to June 2021. So far, in vivo and in vitro scientific evidence is presently existing for several bioactivities. To date, antidiabetic, antidiarrheal, antihyperlipidemic, antipyretic, wound healing, antibacterial, antidementia, antifungal, antiinflammatory, antioxidant, antiplatelet, and bronchorelaxant activities have been scientifically demonstrated for different parts of this plant species. Only an antidiabetic compound {(-)-Fisetinidol-(4α,8)-[(-)-fisetinidol-(4α,6)]-(+)-catechin} has been isolated from this plant species. Further in vitro, in vivo, and clinical studies of various traditional medicinal uses of V. leucophloea should be investigated as well as the bioactive compounds should be identified.
Limonia acidissima Groff is a tree that fits into the Rutaceae family and it is distributed in Asia. This is a food plant and it is also used for medicinal purposes. Its various parts have been using to treat several ailments in ethnomedicines including liver, heart, kidney, eye, and gastric ailments. So far, there is no systematic review available for bioactivities of L. acidissima parts. Hence, this work aims to analyze, summarize, and document the bioactivities and bioactive compounds identified from this plant species. Electronic databases including the Web of Science, Scopus, and ScienceDirect were used to detect published articles linked to bioactivities of L. acidissima from 1900 to October 2020. To date, only in vitro and in vivo level of scientific evidence are available for bioactivities. More investigations have been carried out for anticancer, antifungal, and antioxidant activities. Four bioactive compounds have been identified only for antifungal and cardioprotective activities. Only traditional medicinal treatments for tumors, diabetes, diarrhea, heart disorders, urinary tract illnesses, wound healing, and liver diseases have scientific evidence at present. This work analyzed, summarized, and documented the bioactivities of the extracts and compounds isolated from L. acidissima.
Diabetes is a disease in which the body does not produce insulin or cannot use insulin effectively. In Sri Lanka, 1.2 million people among the age group of 20 to 79 were affected by diabetes in 2019. Biomedicine antidiabetic medications cause common side effects such as bladder cancer, dehydration, sinusitis, kidney illness, and urinary infections. Consumption of green leafy vegetables minimizes the risk of developing diabetes. Hence, this work aims to identify and document the green leafy vegetables currently sold in Trincomalee District in Sri Lanka by performing fieldwork visits to the main markets and the surrounding green leafy vegetable kiosks, shops, superstores, and streets from January 2019 to June 2021. The levels of antidiabetic scientific evidence available for the identified green leafy vegetable species were assessed by recognizing the relevant published works in the electronic databases Web of Science, PubMed, Scopus, etc., until September 2021. A total of 99 green leafy vegetable species from 43 families were recognized. The majority of the green leafy vegetables had in vivo (33%), followed by in vitro (16%) and clinical (9%) as scientific evidences. Also, 49 antidiabetic compounds were already isolated from the identified green leafy vegetables. This study forms a foundation for further studies using the green leafy vegetable species in Trincomalee. ÖZ Diyabet, insülinin vücut tarafından üretilmediği veya etkili bir şekilde kullanılamadığı bir hastalıktır. 2019 yılında, Sri Lanka'da 20 ila 79 yaş arası 1,2 milyon kişi diyabetten etkilenmiştir. Biyomedikal antidiyabetik ilaçlar, mesane kanseri, dehidratasyon, sinüzit, böbrek hastalığı veya idrar yolu enfeksiyonları gibi yaygın yan etkilere neden olabilir. Yeşil yapraklı sebzelerin tüketilmesi diyabet gelişme riskini azaltır. Bu çalışmada, Ocak 2019-Haziran 2021 tarihleri arasında, Sri Lanka'nın Trincomalee Bölgesi'nde bulunan başlıca pazarlarda ve yeşil yapraklı sebze satan büfeler, dükkanlar, süpermarketler ve sokak satıcıları ziyaret edilerek yapılan saha çalışması sonucunda satılan yeşil yapraklı sebzeleri belirlemek ve raporlamak amaçlanmaktadır. Tespit edilen yeşil yapraklı sebze türleri için mevcut antidiyabetik etkisine yönelik bilimsel kanıt seviyeleri, Web of Science, PubMed, Scopus vb. elektronik veri tabanlarında Eylül 2021'e kadar yayınlanmış ilgili çalışmalar tanınarak değerlendirilmiştir. Toplamda 43 familyaya ait 99 yeşil yapraklı sebze tanımlanmıştır. Bilimsel kanıt olarak, yeşil yapraklı sebzelerin çoğu üzerinde yapılmış in vivo (33% ) çalışmalar olup daha sonra, in vitro (16%) ve klinik çalışmalar (9%) gelmektedir. Ayrıca belirlenmiş yeşil yapraklı sebzelerden izole edildiği bilinen 49 antidiyabetik etkili bileşik bulunduğu belirlenmiştir. Bu çalışma, Trincomalee'deki yeşil yapraklı sebze türlerinin kullanımına yönelik sonraki çalışmalar için bir kaynak oluşturacaktır.
Pandanus odorifer (Forssk.) Kuntze belongs to the Pandanaceae family. P. odorifer is used in traditional medicines to treat diabetes, jaundice, skin diseases, brain disorders, and urinary tract illnesses. This work aims to present a comprehensive review to analyze, summarize, and document the reported pharmacological activities of this plant species. Compounds such as eugenol, capric acid, germacrene B, camphor, and linalool have been discovered in this plant species. The major electronic databases (Web of Science, PubMed, ScienceDirect, and Scopus) were applied to identify the relevant published studies from 1900 to June 2021. In vitro and in vivo level of scientific evidence of pharmacological activities of various extracts and active compounds of this plant species is available at the moment. Pharmacological investigations show that P. odorifer possesses such as antioxidant, chemoprotective, antidepressant, antidiabetic, anti-inflammatory, and hepatoprotective activities. This work provides a basis for further pharmacological and phytochemical researches using P. odorifer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.